On Wednesday, Wells Fargo & Co (NYSE:WFC)’s shares inclined 0.45% to $53.71.
A majority of investors have taken advantage of low interest rates, according to the third quarter Wells Fargo/Gallup Investor and Retirement Optimism Index survey. The survey of 1,006 U.S. investors was conducted August 7-16; the median age of the stepped down investors is 70 and the non-stepped down is 45.
Six in 10 investors (58%) are benefiting from lower rates either by taking out a car loan (30%), refinancing an existing mortgage or home finance loan (17%), taking out a mortgage for a new home (16%), obtaining a student loan for themselves or a family member (9%), or taking out another type of loan (10%) over the past two years. Half of investors say they are very or somewhat likely to take out a loan in the near future in anticipation that rates may go up.
Interestingly, forty-four percent of investors say they would make major adjustments to their investment strategy if interest rates rise. The most common action investors anticipate making is buying more stocks (30%), while just 8% say they would reduce their stock holdings. About a quarter (23%) say they would buy bonds or other fixed income investments, whereas 10% say they would sell these types of instruments.
Wells Fargo & Company provides retail, commercial, and corporate banking services to individuals, businesses, and institutions. Its Community Banking segment offers checking, savings, market rate, individual retirement, and health savings accounts, in addition to time deposits and remittances; and lines of credit, auto floor plan lines, equity lines and loans, equipment and transportation loans, education and residential mortgage loans, and debit and credit cards.
Merck & Co., Inc. (NYSE:MRK)’s shares gained 0.56% to $53.85.
MSD, known as Merck (MRK) in the United States and Canada, recently declared that omarigliptin, MSD’s investigational once-weekly DPP-4 inhibitor in development for adults with type 2 diabetes, achieved its primary efficacy endpoint in a Phase 3 study. Omarigliptin was found to be non-inferior to MSD’s once-daily DPP-4 inhibitor, JANUVIA® (sitagliptin), at reducing patients’ HbA1c* levels from baseline, with similar HbA1c reductions achieved in both groups. The head-to-head study was designed to evaluate once-weekly treatment with omarigliptin 25 mg contrast to 100 mg of JANUVIA once daily, a widely prescribed DPP-4 inhibitor worldwide. Results were presented during an oral session at the 51st European Association for the Study of Diabetes (EASD) Annual Meeting.
MSD presented a new drug application to the Japanese Pharmaceuticals and Medical Devices Agency in November 2014 and plans to submit for regulatory approval of omarigliptin in the United States by the end of 2015. The clinical development program for omarigliptin, O-QWEST (Omarigliptin Q Weekly Efficacy and Safety in Type 2 Diabetes), comprises 10 Phase 3 clinical trials involving about 8,000 patients with type 2 diabetes.
Merck & Co., Inc. provides health care solutions worldwide. The company offer therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal infections, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, male pattern hair loss, and fertility diseases.
At the end of Wednesday’s trade, Suncor Energy Inc. (USA) (NYSE:SU)‘s shares surged 4.64% to $26.40.
Suncor Energy’s 2015 Report on Sustainability talk about the company’s approach to delivering environmental, social and economic performance and provides the company’s perspective on the role hydrocarbons will play as the world transitions to a low carbon future.
Beyond reporting Suncor’s progress in environment, social and economic areas, the report comprises frank talk about on topical issues, counting:
- A talk about about energy systems and Suncor’s values with Steve Williams, president and chief executive officer
- A conversation with Arlene Strom, vice president, sustainability & communications on preceding ties counting greenhouse gas emissions, social progress in our communities and Aboriginal Peoples
- A Q&A on climate change and carbon pricing with Fiona Jones, general manager, sustainability
- A video interview where several employees share their thoughts on Suncor’s impact on the environment
Suncor Energy Inc. operates as an integrated energy company. The company primarily focuses on developing petroleum resource basins in Canada’s Athabasca oil sands; explores, acquires, develops, produces, and markets crude oil and natural gas in Canada and internationally; transports and refines crude oil; markets petroleum and petrochemical products primarily in Canada; and markets third party petroleum products. It operates in Oil Sands; Exploration and Production; Refining and Marketing; and Corporate, Energy Trading, and Eliminations segments.
Anadarko Petroleum Corporation (NYSE:APC), ended its Wednesday’s trading session with 5.17% gain, and closed at $69.12.
Anadarko Petroleum Corporation (APC) declared the election of Dr. Sean Gourley to serve as an independent director of the company, effective Sept. 15, 2015.
Additionally, Anadarko declared Amanda M. McMillian, formerly Vice President, Deputy General Counsel, Corporate Secretary and Chief Compliance Officer, has been promoted to Senior Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer. Anadarko’s Robert K. (Bobby) Reeves, formerly Executive Vice President, General Counsel and Chief Administrative Officer, will assume the new title of Executive Vice President, Law and Chief Administrative Officer, and will continue to serve as a member of the company’s executive committee.
- SEAN GOURLEY
Dr. Gourley, 36, is the founder and CEO of Primer, an early-stage, venture-backed company building software to power artificial intelligence applications. Preceding to founding Primer, he was the founder and Chief Technology Officer of Quid, a San Francisco-based augmented intelligence company building software for planned decision-making. Quid was a finalist for Innovative Company in Big Data by Fast Company magazine in 2013. Born in New Zealand, Dr. Gourley studied at Oxford as a Rhodes Scholar where he received a Ph.D. in physics, and he received both his Bachelor of Science and Master of Science in physics from the University of Canterbury in Christchurch, New Zealand. He was additionally a Post-Doctoral Research Fellow at the Said Business School at Oxford University and is presently an Equity Partner with Data Collective Venture Capital Fund, investing in key data and algorithmic technologies.
Anadarko Petroleum Corporation engages in the exploration, development, production, and marketing of oil and gas properties. It operates through three segments: Oil and Gas Exploration and Production; Midstream; and Marketing. The Oil and Gas Exploration and Production segment explores for and produces natural gas, oil, condensate, and natural gas liquids (NGLs).
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
